Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

686
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
686
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.0K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.1K
Overview
80.1K
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

2.2K
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
2.2K
Ion Channels01:19

Ion Channels

91.4K
The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow...
91.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent.

Signal transduction and targeted therapy·2026
Same author

Learning using switching synaptic plasticity rules.

bioRxiv : the preprint server for biology·2026
Same author

Activity-dependent antioxidant gene therapy protects against epileptogenesis.

Signal transduction and targeted therapy·2026
Same author

Towards a Unified Research Agenda: International Consensus to Advance Understanding and Prevention of Sudden Unexpected Death in Epilepsy.

Epilepsy currents·2026
Same author

An artefact-resilient wide bandwidth bidirectional graphene neural interface.

Nature communications·2026
Same author

Energy metabolism, adenosine, and glutamate signaling reprogramming by decanoic acid in Glut1 disorder syndrome.

Epilepsia open·2026
Same journal

Does stimulus preceding negativity reflect predictions in a somatosensory roving paradigm?

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same journal

Temporal Dynamics of EEG Reflect Continuous Error Correction During Force Control.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same journal

Frontoparietal Hub Connectivity Integrates Information from Multiple Sources.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same journal

Mapping the Heart-Brain Continuum beyond Heart Failure: Why Neurology Matters.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same journal

Emergence of behavioral tinnitus in gerbils is associated with reduced spontaneous rates in single auditory nerve fibers.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same journal

Decoding the neural stages from action and object recognition to mentalizing.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.6K

Epilepsy Gene Therapy Using an Engineered Potassium Channel.

Albert Snowball1, Elodie Chabrol1, Robert C Wykes1

  • 1Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|February 14, 2019
PubMed
Summary
This summary is machine-generated.

A novel gene therapy using an engineered potassium channel (EKC) effectively reduces seizures in preclinical epilepsy models. This safe and targeted approach shows promise for treating refractory focal epilepsy, addressing a significant unmet medical need.

Keywords:
EEGepilepsygene therapylentiviruspotassium channelseizure detection

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.0K
Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

29.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
10:07

High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels

Published on: January 27, 2013

15.6K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

6.0K
Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

29.2K

Area of Science:

  • Neuroscience and Gene Therapy
  • Development of novel therapeutic strategies for neurological disorders

Background:

  • Refractory focal epilepsy presents a significant treatment challenge, with limited options for patients unresponsive to conventional therapies.
  • Existing treatments like epilepsy surgery carry risks to normal brain function, highlighting the need for safer alternatives.
  • Gene therapy offers a promising avenue, but requires careful vector design to balance safety and efficacy in brain tissue.

Purpose of the Study:

  • To develop and optimize an epilepsy gene therapy vector for clinical translation.
  • To engineer a voltage-gated potassium channel (Kv1.1) for enhanced function and safety.
  • To evaluate the efficacy and safety of the engineered gene therapy in preclinical epilepsy models.

Main Methods:

  • Codon optimization and mutation of the KCNA1 gene encoding Kv1.1 to create an engineered potassium channel (EKC).
  • Packaging the EKC gene into a non-integrating lentiviral vector with a cell type-specific CAMK2A promoter for targeted delivery.
  • Conducting blinded, randomized, placebo-controlled preclinical trials in rat models of focal neocortical and temporal lobe epilepsy.

Main Results:

  • The EKC lentivector significantly reduced seizure frequency in a rat model of focal neocortical epilepsy.
  • Adeno-associated viral vector (AAV2/9) delivery of the EKC gene suppressed seizures in a temporal lobe epilepsy rat model.
  • The engineered gene therapy demonstrated efficacy with improved safety due to cell-type specific expression and non-integrating delivery.

Conclusions:

  • Engineered potassium channel (EKC) gene therapy is a viable and safe approach for treating refractory focal epilepsy.
  • Cell type-specific expression and integration-deficient vectors enhance safety profiles for brain gene therapies.
  • The developed EKC gene therapy is ready for clinical translation to address a major unmet need in epilepsy treatment.